Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest LaboratoriesNSE:QUESTLAB -0.61%46 EV-to-OCF is -13.22 as of Aug. 10, 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 46/100. The stock has 5 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Quest Laboratories ranks better than 84.1% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Quest Laboratories's Enterprise Value is ₹1,417 Mil.
Quest Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-107 Mil. Therefore, Quest Laboratories's EV-to-OCF for today is -13.22.
The historical rank and industry rank for Quest Laboratories's EV-to-OCF or its related term are showing as below:
NSE:QUESTLAB'
s EV-to-OCF Range Over the Past 10 Years
Min: -22.7 Med: -5.49 Max: 85.67
Current: -13.22
During the past 6 years, the highest EV-to-OCF of Quest Laboratories was 85.67. The lowest was -22.70. And the median was -5.49.
NSE:QUESTLAB's EV-to-OCF is ranked better than 84.1% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 11.1
vs NSE:QUESTLAB: -13.22
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Quest Laboratories's PE Ratio (TTM) for today is calculated as:
Quest Laboratories's share price for today is ₹89.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.160.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Quest Laboratories EV-to-OCF Related Terms
Quest Laboratories EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: EV-to-OCF Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's EV-to-OCF falls into.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-107 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a EV-to-OCF of -13.22 as of Aug. 10, 2026. According to the industry distribution chart, Quest Laboratories ranks #160 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 15.9%.
Is Quest Laboratories' EV-to-OCF too high?
Quest Laboratories' current EV-to-OCF is -13.22. Based on the distribution chart, Quest Laboratories ranks #160 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Quest Laboratories has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' EV-to-OCF compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #160 out of 1006 companies for EV-to-OCF. This places Quest Laboratories in the top 16% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 11.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 11.10, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current EV-to-OCF is -13.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current EV-to-OCF of -13.22. The current EV-to-OCF is -13.22. Quest Laboratories' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current EV-to-OCF is -13.22 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
46GF Score
Get the complete analysis for NSE:QUESTLAB
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
